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suggest that the virus also requires the AdoMet-depen-mRNA Cap-1 Methyltransferase
dent cap-0 methyltransferase. Both functions can bein the SARS Genome inhibited by carbocyclic analogs of adenosine, such as
Neplanocin A or 3-deazaneplanocin A, which interfere
with the AdoMet-AdoHcy metabolism of the host cell
(De Clercq, 1998; Bray et al., 2002). Those compounds
The 3D jury system has predicted the methyltransfer- could complement other therapeutic strategies aimed
ase fold for the nsp13 protein of the SARS coronavirus. at blocking enzymatic functions such as the RNA-
Based on the conservation of a characteristic tetrad of dependent RNA polymerase, the protease, or the heli-
residues, the mRNA cap-1 methyltransferase function case encoded by the SARS virus.
has been assigned to this protein, which has potential
implications for antiviral therapy.
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The latest outbreak of the severe acute respiratory syn- BioInfoBank Institute
drome (SARS) epidemic has led to thousands of poten- Limanowskiego 24A
tially lethally infected patients and hundreds of deaths. 60-744 Poznan
These numbers are likely to rise, and the spreading dis- Poland
ease is already causing major medical and economical
*Correspondence: leszek@bioinfo.plconcerns. Meanwhile, the SARS coronavirus identified
as the pathogen responsible for the disaster has been
isolated, and its genome sequenced (Marra et al., 2003;
Rota et al., 2003).
We have applied the 3D jury meta predictor (Ginalski
et al., 2003) to annotate the structure and function of
proteins encoded by the viral positive-strand ssRNA.
Novel fold recognition methods utilize the global net-
work of independent structure prediction servers. De-
tection of patterns of structural similarity between di-
verse models is used to consistently select the correct
fold from a set of borderline predictions. Such methods
made a dramatic impact on the last critical assessment
of protein structure prediction (CASP-5 experiment)
conducted in the summer of 2002. One of the most
interesting findings obtained during the SARS genome
annotation process is a surprisingly reliable (3D jury
score 100) assignment of the methyltransferase fold
to the nsp13 (GI:30133975) domain located in the
C-terminal part of the almost 7000 amino acid large
pp1ab viral polyprotein (Figure 1). Standard sequence
comparison tools such as PSI-BLAST or RPS-BLAST
applied using the conserved domain database (March-
ler-Bauer et al., 2003) failed to assign any function to
this domain. The domain belongs to the ancient family
of AdoMet-dependent ribose 2-O-methyltransferases,
which has been adapted by numerous viruses before
the three domains of life evolved form the last universal
common ancestor (LUCA) (Feder et al., 2003). The enzy-
matic role of the protein was confirmed by the presence
of the conserved tetrad of residues K-D-K-E essential
for mRNA cap-1 (mGpppNm) formation. Figure 1. 3D Model of the nsp13 Domain of the SARS Coronavirus
The mRNA cap methylation is found indispensable for pp1ab Polyprotein
efficient replication of many viruses (Bach et al., 1995; This model is based on the reassigned (Bujnicki and Rychlewski,
2001) cap-1 methyltransferase of the reovirus 2 protein (1ej6 [Rein-Woyciniuk et al., 1995; Vlot et al., 2002) and represents
isch et al., 2000]). While other templates (1eiz or 1ej0) obtainedan active area for drug development. Nevertheless, di-
marginally higher 3D jury scores, the selected template had therect inhibitors of the nsp13 enzyme may fail to suppress
lowest number of insertions and deletions. Side chains of the con-viral replication, as the cap-1 formation seems to be less
served tetrad of residues (K-D-K-E) essential for cap-1 methylation
critical than the preceding cap-0 (mGpppN) formation and the docked AdoMet cofactor are shown. Four blocks of aligned
(Latner et al., 2002; Wu and Guarino, 2003). The exis- motifs containing the conserved, function-specific residues are
shown in upper right corner.tence of the cap-1-forming enzyme in the genome would
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